RETRACTED: Surface PEGylation of ZIF-8 metal-organic framework based on magnetic hydroxyapatite as a pH/magnetic targeting responsive system for anticancer drug delivery

Abstract

In the present study, a zinc-based metal-organic framework/magnetic hydroxyapatite nanocomposite (Fe3O4@SiO2@HAp@ZIF-8) as new targeting drug delivery system was synthesized through the solvothermal method. Then, Fe3O4@SiO2@HAp@ZIF-8 was coated with a biocompatible layer of polyethylene glycol (PEG) (Fe3O4@SiO2@HAp@ZIF-8-PEG). The structural features of these nanocomposites were characterized using FT-IR, XRD, FE-SEM, EDX, TEM, Zeta potential, BET, and VSM analysis. The Fe3O4@SiO2@HAp@ZIF-8 and Fe3O4@SiO2@HAp@ZIF-8-PEG were applied as a carrier to encapsulate the doxorubicin (DOX) as an anticancer drug. The drug loading capacity and encapsulation efficiency of Fe3O4@SiO2@HAp@ZIF-8 and Fe3O4@SiO2@HAp@ZIF-8-PEG were 7.6, 76.09, 9.8, and 98.12%, respectively. Moreover, a drug release study revealed that both nanocomposites were pH-dependent because of the dissolution of HAp under acidic conditions. The release kinetics of DOX from the prepared nanocomposites at pH 5 also showed that the Korsmeyer-Peppas model was the best model to describe the release mechanism of DOX from prepared systems. The in vitro cell viability results showed that synthesized systems had no significant toxicity, while DOX-loaded systems had notable and higher toxicity against A549 human lung carcinoma cell lines. The DPPH tests also showed that the prepared Fe3O4@SiO2@HAp@ZIF-8-PEG nanocomposites have excellent antioxidant activity. Therefore, all obtained results clearly suggest that the as-prepared drug systems are potential and suitable candidates for targeted drug delivery applications.